10 Sep History of CMT Research at the University of Washington
Presented at the 2018 CMTA Seattle Patient & Family Conference
by Thomas Bird, MD
Director of the Neurogenetics Clinic
University of Washington
Dr. Thomas Bird is one of the founders of the field of clinical neurogenetics in this country, having established the first adult neurogenetics clinic at the University of Washington in 1974. His research career has focused on disease gene identification and genotype/phenotype correlations.
Dr. Bird and his colleagues have identified causative mutations in genes affecting a broad range of neurogenetics disorders including early onset Alzheimer disease (PSEN2), frontotemporal dementia (MAPT), CMT1B (MPZ), HNPP (PMP-22 del), and CMT1C (SIMPLE/LITAF).
Dr. Bird is head of the Division of Neurogenetics in the UW Department of Neurology and an investigator in the Geriatrics Research Education and Clinical Center at the VAPSHCS, the UW Alzheimer’s Disease Research Center and the UW Center for Human Development and Disability. He is Emeritus Professor of Neurology and Medical Genetics at the University of Washington.